Go to content
UR Home

Entries of Zugmaier, Gerhard on the publication server

Up a level
Export as
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item type | No Grouping
Number of items: 6.

Gökbuget, Nicola, Zugmaier, Gerhard, Dombret, Hervé, Stein, Anthony, Bonifacio, Massimiliano, Graux, Carlos, Faul, Christoph, Brüggemann, Monika, Taylor, Kate, Mergen, Noemi, Reichle, Albrecht, Horst, Heinz-August, Havelange, Violaine, Topp, Max S. and Bargou, Ralf C. (2020) Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia. Leukemia & Lymphoma 61 (11), pp. 2665-2673. Fulltext not available.

Bargou, Ralf C., Nagorsen, Dirk, Zugmaier, Gerhard, Benjamin, Jonathan E., Haddad, Vincent, Wessels, Hendrik, Stieglmaier, Julia, Havelange, Violaine, Horst, Heinz-August, Brüggemann, Monika, Topp, Max S., Diedrich, Helmut, Faul, Christoph, Graux, Carlos, Reichle, Albrecht, Bonifacio, Massimiliano, Dombret, Hervé and Gökbuget, Nicola (2018) Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. Blood 131 (14), pp. 1522-1531. Fulltext not available.

Zugmaier, Gerhard, Gökbuget, Nicola, Klinger, Matthias, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz-A., Marks, Reinhard, Faul, Christoph, Diedrich, Helmut, Reichle, Albrecht, Brüggemann, Monika, Holland, Chris, Schmidt, Margit, Einsele, Hermann, Bargou, Ralf C. and Topp, Max S. (2015) Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment. Blood 126 (24), pp. 2578-2584. Fulltext not available.

Topp, Max S., Gökbuget, Nicola, Zugmaier, Gerhard, Klappers, Petra, Stelljes, Matthias, Neumann, Svenja, Viardot, Andreas, Marks, Reinhard, Diedrich, Helmut, Faul, Christoph, Reichle, Albrecht, Horst, Heinz-August, Brüggemann, Monika, Wessiepe, Dorothea, Holland, Chris, Alekar, Shilpa, Mergen, Noemi, Einsele, Hermann, Hoelzer, Dieter and Bargou, Ralf C. (2014) Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 32 (36), pp. 4134-4140. Fulltext not available.

Topp, Max, Goekbuget, Nicola, Zugmaier, Gerhard, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz-August, Reichle, Albrecht, Marks, Reinhard, Monika, Brueggemann, Ritgen, Matthias, Klappers, Petra, Mergen, Noemi, Goebeler, Marie-Elisabeth, Einsele, Hermann, Hoelzer, Dieter and Bargou, Ralph (2012) Effect of anti-CD19 BiTE blinatumomab on complete remission rate and overall survival in adult patients with relapsed/refractory B-precursor ALL. Journal of Clinical Oncology 30 (15_sup), p. 6500. Fulltext not available.

Topp, Max S., Goekbuget, Nicola, Zugmaier, Gerhard, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz A., Reichle, Albrecht, Marks, Reinhard E, Brueggemann, Monika, Ritgen, Matthias, Klappers, Petra, Mergen, Noemi, Goebeler, Marie-Elisabeth, Einsele, Hermann, Hoelzer, Dieter and Bargou, Ralf (2011) Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial. Blood 118 (21), p. 252. Fulltext not available.

This list was generated on Fri May 16 10:21:09 2025 CEST.
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons